E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 11/9/2006 in the Prospect News Biotech Daily.

Connetics on hold by Jefferies

Jefferies & Co., Inc. analyst David Windley maintained Connetics Corp. at a hold rating as company management carried through with its plans to slash wholesaler inventories, now down to an average of 6 to 7 weeks, with additional reductions expected in the fourth quarter. Connetics reported a per-share loss of 81 cents for the September, compared to the analyst's estimate of a 67 cent loss per share. Shares of the Palo Alto, Calif.-based specialty pharmaceutical company were down 14 cents, or 0.82%, at $16.91. (Nasdaq: CNCT)


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.